These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4790145)

  • 41. Drug Effects on the Thyroid.
    Burch HB
    N Engl J Med; 2019 Aug; 381(8):749-761. PubMed ID: 31433922
    [No Abstract]   [Full Text] [Related]  

  • 42. Amantadine and drug metabolism.
    O'Malley K; Stevenson IH; Turnbull MJ
    Lancet; 1972 Mar; 1(7752):685. PubMed ID: 4125185
    [No Abstract]   [Full Text] [Related]  

  • 43. Drug metabolism and disposition at varying levels of protein and calories in human subjects.
    Nutr Rev; 1985 Mar; 43(3):71-2. PubMed ID: 3887240
    [No Abstract]   [Full Text] [Related]  

  • 44. Influence of ascorbic acid and erythorbic acid on drug metabolism in the cynomolgus monkey.
    Omaye ST; Green MD; Turnbull JD; Amos WH; Sauberlich HE
    J Clin Pharmacol; 1980 Apr; 20(4):172-83. PubMed ID: 6769978
    [No Abstract]   [Full Text] [Related]  

  • 45. Are there foods that support thyroid health?
    Cunningham E
    J Acad Nutr Diet; 2012 Apr; 112(4):588. PubMed ID: 22709707
    [No Abstract]   [Full Text] [Related]  

  • 46. Obesity and fasting--effects on drug metabolism and drug action in man.
    Reidenberg MM
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 2):729-34. PubMed ID: 913031
    [No Abstract]   [Full Text] [Related]  

  • 47. Interindividual variations in drug disposition. Clinical implications and methods of investigation.
    Breimer DD
    Clin Pharmacokinet; 1983; 8(5):371-7. PubMed ID: 6627809
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug metabolism in thyroid disease.
    Eichelbaum M
    Clin Pharmacokinet; 1976; 1(5):339-50. PubMed ID: 797503
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of thyroid dysfunction on drug pharmacokinetics.
    Shenfield GM
    Clin Pharmacokinet; 1981; 6(4):275-97. PubMed ID: 6166422
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of thyroid status on plasma half-life of antipyrine in man.
    Eichelbaum M; Bodem G; Gugler R; Schneider-Deters D; Dengler HJ
    N Engl J Med; 1974 May; 290(19):1040-2. PubMed ID: 4821905
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of the thyroid gland on metabolism of estrone and delta-4-androstenedione in the rat ovary].
    Lehmann WD; Lehmann V; Brandau H
    Endokrinologie; 1970; 57(1):115-24. PubMed ID: 5493201
    [No Abstract]   [Full Text] [Related]  

  • 52. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of the functional state of the thyroid gland on the metabolism of estrogens in the microsome fraction of rat liver].
    Lehmann WD; Breuer H
    Acta Endocrinol (Copenh); 1969 Jul; 61(3):461-76. PubMed ID: 5820057
    [No Abstract]   [Full Text] [Related]  

  • 54. [Influence of thyroid function on human drug metabolism].
    Gugler R; Eichelbaum M; Schneider-Deters C; Bodem G; Dengler HJ
    Verh Dtsch Ges Inn Med; 1973; 79():1230-3. PubMed ID: 4790145
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.